As the first two health apps in Germany can now be prescribed with reimbursement, HBI speaks to their founders about how they will actually get the solutions to patients.
UK-based NHS dental specialist IDH, which operates over 600 UK-based clinics as {my}dentist and supplies thousands of dentists with products and equipment through dental supplier DD, is for sale. Could the group could be broken up if the buyer for the whole is not found?
Up to seven different investors are reportedly taking part in the €3.3bn buyout of France's second-largest hospital group Elsan, including family office and insurance funds.
Evercare Group, the operating platform held by the (ex-Abraaj) $1bn Evercare Health Fund, aims to open its Lagos hospital in December this year, Evercare Group CEO Massimiliano Colella tells HBI.
Sources in the Netherlands say Dutch maternity has been struggling this year. HBI understands one group, for-profit Zord in Nederland(ZIN), has received help from its insurers at this troubling time.
Following on from our exclusive story last month confirming Dutch mental health provider Mentaal Beter is for sale, HBI hears there has been considerable interest in the deal.
The temporary authorisation of telemedicine in Brazil will become permanent, HBI is told by a source close to the decision-making process, as the country's legislature is set to unveil a new law in Q4/1.
India's largest dialysis provider NephroPlus has acquired the fourth-largest private operator in the Philippines, while its home haemodialysis volumes have tripled during the pandemic in India, CEO Vikram Vuppala tells HBI.
UK Addiction Treatment claims 97% occupancy within a week of opening its latest facility. But would you invest in a business run by addicts for addicts? Or whose majority investor, Global Group, has recently seen its founder, Greg Lindbergh, jailed for bribing a US official? We talk to UKAT CEO, Eytan Alexander. Seven years ago, […]
Intermediate Capital Group (ICG) is indirectly acquiring over 25% of the shares of Europe's largest radiopharmaceuticals provider Curium Pharma, HBI can reveal, after owner Capvest earlier pulled a majority sales process because of COVID-19.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
